Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,366 | 300 | 99.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $20.00 | 1 | 0.5% |
| Education | $16.74 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,366 | 98 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $839.99 | 75 | $0 (2024) |
| Gilead Sciences, Inc. | $329.15 | 22 | $0 (2021) |
| Allergan, Inc. | $320.69 | 17 | $0 (2020) |
| Takeda Pharmaceuticals U.S.A., Inc. | $257.22 | 15 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $197.38 | 12 | $0 (2017) |
| Janssen Biotech, Inc. | $196.51 | 13 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $192.85 | 6 | $0 (2024) |
| PFIZER INC. | $174.21 | 12 | $0 (2023) |
| Synergy Pharmaceuticals Inc | $95.20 | 5 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $347.15 | 18 | ABBVIE INC. ($152.44) |
| 2023 | $290.42 | 17 | ABBVIE INC. ($210.20) |
| 2022 | $390.78 | 31 | ABBVIE INC. ($192.30) |
| 2021 | $689.52 | 50 | AbbVie Inc. ($250.24) |
| 2020 | $346.86 | 16 | Allergan, Inc. ($122.56) |
| 2019 | $915.03 | 68 | AbbVie, Inc. ($281.53) |
| 2018 | $787.23 | 65 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($232.12) |
| 2017 | $635.45 | 37 | Valeant Pharmaceuticals North America LLC ($197.38) |
All Payment Transactions
302 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: Immunology | ||||||
| 12/16/2024 | ABBVIE INC. | CREON (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $20.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/25/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/14/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: IMMUNOLOGY | ||||||
| 09/19/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: GI | ||||||
| 08/16/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $7.15 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Gastroenterology | ||||||
| 07/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: INTERNAL MEDICINE | ||||||
| 04/26/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: IMMUNOLOGY | ||||||
| 03/22/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $10.38 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/21/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/12/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $5.07 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/04/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: VIROLOGY | ||||||
| 02/26/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: IMMUNOLOGY | ||||||
| 02/09/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $9.84 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/05/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: VIROLOGY | ||||||
| 01/12/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $7.19 | General |
| Category: IMMUNOLOGY | ||||||
| 01/12/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $0.54 | General |
| Category: IMMUNOLOGY | ||||||
| 11/28/2023 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $4.46 | General |
| Category: IMMUNOLOGY | ||||||
| 11/28/2023 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $0.39 | General |
| Category: IMMUNOLOGY | ||||||
| 11/17/2023 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $8.82 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/16/2023 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $107.63 | General |
| Category: IMMUNOLOGY | ||||||
| 10/13/2023 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $8.44 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/20/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 890 | 1,014 | $832,575 | $108,736 |
| 2022 | 10 | 810 | 941 | $744,450 | $98,976 |
| 2021 | 11 | 937 | 1,044 | $754,695 | $107,318 |
| 2020 | 13 | 789 | 889 | $671,380 | $81,573 |
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 142 | 142 | $255,600 | $18,671 | 7.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 128 | 159 | $23,850 | $15,250 | 63.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 120 | 120 | $36,000 | $14,247 | 39.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 140 | 143 | $214,500 | $14,031 | 6.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 144 | 189 | $23,625 | $13,036 | 55.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 54 | 54 | $118,800 | $10,804 | 9.1% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 49 | 49 | $80,850 | $7,176 | 8.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 24 | 62 | $15,500 | $4,194 | 27.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 25 | 25 | $7,500 | $3,640 | 48.5% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 12 | 12 | $19,800 | $2,365 | 11.9% |
| 91065 | Measurement of hydrogen in breath to test for stomach and bowel symptoms | Office | 2023 | 21 | 28 | $11,200 | $1,993 | 17.8% |
| 43251 | Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope with mechanical snare | Facility | 2023 | 11 | 11 | $20,350 | $1,675 | 8.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 20 | 20 | $5,000 | $1,654 | 33.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 126 | 127 | $228,600 | $16,859 | 7.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 127 | 161 | $24,150 | $16,761 | 69.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 142 | 152 | $228,000 | $14,831 | 6.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 96 | 96 | $28,800 | $11,984 | 41.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 118 | 144 | $18,000 | $9,523 | 52.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 39 | 40 | $88,000 | $7,138 | 8.1% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 48 | 48 | $79,200 | $7,116 | 9.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 52 | 106 | $26,500 | $6,201 | 23.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 36 | 36 | $10,800 | $5,860 | 54.3% |
| 91065 | Measurement of hydrogen in breath to test for stomach and bowel symptoms | Office | 2022 | 26 | 31 | $12,400 | $2,705 | 21.8% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 121 | 121 | $217,800 | $16,536 | 7.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 127 | 140 | $21,000 | $15,252 | 72.6% |
About Dr. Philip Micale, M.D
Dr. Philip Micale, M.D is a Specialist healthcare provider based in Teaneck, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1750354346.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Philip Micale, M.D has received a total of $4,402 in payments from pharmaceutical and medical device companies, with $347.15 received in 2024. These payments were reported across 302 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($4,366).
As a Medicare-enrolled provider, Micale has provided services to 3,426 Medicare beneficiaries, totaling 3,888 services with total Medicare billing of $396,603. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Location Teaneck, NJ
- Active Since 02/13/2006
- Last Updated 08/26/2014
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1750354346
Products in Payments
- XIFAXAN (Drug) $526.68
- LINZESS (Drug) $265.45
- Creon (Drug) $246.31
- XELJANZ (Drug) $174.21
- UCERIS (Drug) $173.94
- RINVOQ (Biological) $170.06
- Entyvio (Biological) $164.53
- Mavyret (Drug) $156.11
- Linzess (Drug) $154.84
- SKYRIZI (Biological) $153.09
- HUMIRA (Biological) $144.21
- TRULANCE (Drug) $142.99
- MAVYRET (Drug) $141.66
- VIBERZI (Drug) $132.07
- DALVANCE (Drug) $122.56
- Humira (Biological) $114.45
- ENTYVIO (Biological) $107.29
- MOVIPREP (Drug) $101.68
- STELARA (Biological) $98.40
- Trulance (Drug) $95.20
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Teaneck
Dr. Peter Hersh, M.d, M.D
Specialist — Payments: $72,201
Adam Palance, Md, MD
Specialist — Payments: $11,766
Dr. Ebrahim Issa
Specialist — Payments: $7,680
Dr. Christopher Brown, M.d, M.D
Specialist — Payments: $5,561
Dr. Payal Shah
Specialist — Payments: $3,938
Michael Schmidt, Md, MD
Specialist — Payments: $3,036